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Felinecoronavirus(FCoV)isanenvelopedsingle-strandedRNAvirus,ofthefamilyCoronaviridaeandtheorderNidovirales.FCoV
is an important pathogen of wild and domestic cats and can cause a mild or apparently symptomless enteric infection, especially
in kittens. FCoV is also associated with a lethal, systemic disease known as feline infectious peritonitis (FIP). Although the precise
cause of FIP pathogenesis remains unclear, some hypotheses have been suggested. In this review we present results from diﬀerent
FCoV studies and attempt to elucidate existing theories on the pathogenesis of FCoV infection.
1.Introduction
Feline coronavirus (FCoV) belongs to the family Coron-
aviridae and the order Nidovirales [1]a n da ﬀects both wild
and domestic cats [2]. FCoV contains a positive polarity
RNA genome approximately 29kb in length, consisting of
11 open reading frames (ORFs). Two major ORFs encode a
replicase, four ORFs encode the structural proteins S (spike),
E(envelope),M(membrane),andN(nucleocapsid),andﬁve
ORFsencodethenonstructuralproteins3a,3b,3c,7a,and7b
[3].
FCoV can cause a mild or sometimes apparently symp-
tomless enteric infection, especially in kittens, and is also as-
sociated with a lethal, systemic disease known as feline in-
fectious peritonitis (FIP) [4, 5]. FIP is characterized by ﬁb-
rinous, granulomatous serositis, with protein-rich eﬀusions
in the body cavities of aﬀected cats (eﬀusive or “wet” FIP),
as well as granulomatous-necrotizing lesions, periphlebitis
and granulomatous inﬂammatory lesions in several organs,
especially, liver, kidney, spleen, leptomeninges, and eyes
(noneﬀusive or “dry” FIP) [6].
Although the precise cause of FIP pathogenesis is still
unknown, several hypotheses have been suggested. One as-
sumption is that a mutant FCoV strain is able to infect
monocytes and macrophages, leading to FIP [7–9]. This
mutant virus strain has been named feline infectious peri-
tonitis virus (FIPV), whereas the strain that causes enteric
infection was named feline enteric coronavirus (FECV) [7,
10–12]. Because FIPV and FECV cannot be distinguished
by their antigenicity, or even by genome sequence analysis,
they are considered to be two, distinctly diﬀerent pathotypes,
which diﬀer only in their pathogenicity [11, 12]. In fact,
although this hypothesis is known as the internal mutation
theory, no speciﬁc mutation has been identiﬁed in the 29kb
FCoV genome [13].
AsecondhypothesisforthedevelopmentofFIPproposes
that any FCoV strain can cause FIP disease. Instead, host fac-
tors, such as immune response variations [13–16], and viral
factors,suchastheformationofquasispecies[17],determine
whether or not FIP develops.
Brownetal.[18]haveproposed yetathirdhypothesisfor
FIP pathogenesis. These authors suggest, after phylogenetic2 Advances in Virology
Table 1: Hypotheses regarding the FIP pathogenesis.
Theory References
Internal mutation theory [2, 5, 7, 9, 19–26]
Quasispecies theory [13, 17, 27]
Immune response related to viral-host
interaction
[6, 11, 14, 16, 32, 36,
40–46, 48–60, 62–
64, 67–70]
Distinctive circulating virulent and
avirulent strains [18]
analyses, of the partial membrane gene and the partial non-
structural protein 7b gene from sequences from healthy
cats and sick cats that, possibly, there are two diﬀerent
strains, virulent and avirulent, circulating in natural feline
population and FIP development occurs when an animal
is infected with the virulent strain.
Thus, to date, many experimental studies and diﬀerent
hypothesis have been reported in the literature attempting
to explain FIP pathogenesis (Table 1). This review, there-
fore, presents these diﬀerent research studies and attempts
to elucidate existing theories on the pathogenesis of FCoV
infection.
2. InternalMutationTheory
The close similarity of FECV to FIPV, and the low incidence
ofFIP, despite the high proportion of FCoV seropositive cats,
led to the hypothesis that FECV carriers are sources of FIPV,
which is proposed to be generated by small mutations in
FECV [5, 19]. After this hypothesis was ﬁrst postulated in
the literature, several studies have been conducted to test its
validity.
Initially,thismutationaltheorywasquestioned,whenthe
3  ends of the genomes (the corresponding ORF7a/7b) of
an FIPV strain, which had been adapted to tissue culture
(strain WSU 79-1146), and an FECV strain (strain WSU
79-1683) were genetically compared. FECV was shown to
contain a 238-nucleotide deletion in ORF7b [20], in contrast
to what might be expected if FIPV were indeed a mutant
of FECV. According to Vennema et al. [20], it is possible
that both FECV and avirulent FIPV strains are derived
from FIP inducing strains but have been attenuated by
the loss of virulence factors. The authors further propose
that recombination of two attenuated viruses during a rare
mixed infection event could result in the resurgence of a
virulent FIPV strain.
Evidence in support of the mutation theory came from
comparative analysis of 1.2kb genomic fragments obtained
from nine additional FECV and FIPV isolates [21]. All of
these isolates were found to have intact ORF7bs, indicating
that the deletion observed in FECV 79-1683 is associated
withadaptationtocellculture.Theseresultsareinagreement
with previous studies that showed that four strains of FCoV
(79-1683, TN406-HP, UCD2, and ts-DF2) with deletions
in ORF7b were avirulent [22, 28]. Thus, it is likely that,
for these viruses, ORF7b deletions contribute to the loss
of virulence. Therefore, ORF7b seems to provide a distinct
selective advantage during natural infection [21].
Because ORF7b deletions had been identiﬁed in previous
studies, researchers began to assess the involvement of other
regions of the genome in FCoV pathogenicity. Subsequent
studies have shown that both deletions and nonsense
mutations within ORF3c and, less often, speciﬁc mutations
in OFR7b are present in FIPVs but not in FECVs [9].
Sequencing of attenuated derivatives of virulent FIPV strains
shows good correlation between deletions in ORF7b and
attenuation of virulence [21]. This latter observation indi-
cates that the 7b protein encoded by ORF7b is important
for virulence. Thus, the virulence-associated ORF7b may
be somewhat suppressed in FECVs not adapted to tissue
culture, and the presence of an intact ORF3c in these FECVs
may be involved in this suppression. Moreover, two cats
from the same household were found to contain distinct
ORF3c deletions, demonstrating that these two FIPVs were
independently derived from FECV and not transmitted
horizontally [9].
Kennedy et al. [23] analyzed ORF7a and ORF7b in chee-
tah FCoVs over a period of 4 years. In most isolates, a
deletion mutation was observed in ORF7a that results in an
open reading frame change, possibly leading to expression
of an aberrant ORF7a product, or loss of ORF7a expression.
In addition, although speciﬁc mutations were also found
in ORF7b, these mutations would not result in important
changes within the resulting protein, suggesting that this
protein may be essential for viral replication or infection
[23].
Subsequent analysis of ORF7a and ORF7b revealed two
distinct virus variants circulating in a population of 15
Persian cats: one with ORF7a intact and the other with two
major deletions (nucleotides 20–120 and nucleotides 164–
226) in ORF7a [24]. ORF7b was intact and similar among
all isolates, but speciﬁc mutations resulted in changes in
ORF7b protein amino acids. Some cats in this study were
doubly infected with both viral variants. Because the cats
were exposed to both variants, the authors concluded that
there must be a causal relationship between the occurrence
of these mutations and the increased incidence of FIP in this
population [24]. According to these authors, in addition to
the viral variant, disease variation must be related to host
factors, such as the ability of the host to generate an eﬀective
immune response.
Alternatively, many authors have proposed that muta-
tions in other genomic regions might be responsible for
the variation in virulence observed in FCoV strains [8, 25].
Speciﬁcally, analysis of the 5  hypervariable region of the S
gene revealed consecutive accumulation of nucleotide sub-
stitutions nonsynonymous in this region, suggesting sequen-
tial emergence of viral variants, each time replacing the pre-
existingviruspopulationasaresultofimmuneselectiondur-
ing chronic infection [25].
Because deletions in ORF7b were previously identiﬁed
in laboratory strains with variable numbers of passages,
these were considered to be associated with loss of virulence
[20, 21, 29]. In contrast to these previous ﬁndings, sequence
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FIP revealed small, in-frame deletions in the 3  region of
ORF7b, implying that the presence of this deletion is not
correlated with FIP pathogenicity [30].
Studies have also shown that ORF3c presents great ge-
netic variability in cats with FIP [2, 26]. The expression of
functional ORF3c protein is crucial for FECV replication in
the gut, but dispensable for systemic FIPV replication [26]. It
was observed that ORF3c is intact in all strains of FECVs, but
it is mutated in most FIPV strains. However, as some FIPVs
seem to have intact ORF3c, it is likely that 3c mutations are
not the only cause of FIP [2, 26].
To investigate the genetic diﬀerences that may result in
the increased pathogenicity of FIPV with respect to FECV,
Dye and Siddell [13] compared the complete sequences of
viral RNA samples extracted from the liver and jejunum of a
cat with classical FIP and observed 100% identity between
them, calling into question the internal mutation theory.
However, studies in support of this theory contend that,
becausedeleteriousORF3cmutationstendtobefoundinthe
tissuesofsickanimals,whileintactORF3cisfoundmainlyin
feces [2], fecal samples of FIPV may be present as a result of
extensive intestinal lesions, which could explain the presence
of the FIPV in the jejunum in the experiments carried out by
Dye and Siddell [13].
Sequence comparisons also show that FECVs and FIPVs
taken from cats in the same geographical area are closely
related, whereas there are signiﬁcant genetic variations be-
tween FECVs and FIPVs from diﬀerent geographic areas
[2, 9]. According to these authors, the high genetic similarity
between FIPV and FECV isolates from cats of the same
geographic region strongly suggest a common ancestor. Fur-
thermore, the occurrence of deleterious mutations in FIPVs,
but not in FECVs, is believed to conﬁrm the hypothesis that
FIPVs emerged from FECVs.
The theory that FIPVs originated from mutations in
FECVs was reinforced by studies of experimental infection.
Cats experimentally infected with an FECV RM strain [7]
remained asymptomatic during the ﬁrst 2 months postin-
fection, but 8 to 10 weeks postinfection, 2 cats developed
FIP. Viruses isolated from these two cats (FIPV-UCD9 and
FIPV-UCD10) were found to have high sequence identity
with each other and with FECV-RM and induced FIP when
inoculated intraperitoneally in speciﬁc pathogen-free (SPF)
cats [7]. This study showed that FIPVs can rapidly arise by
mutations in FECVs and that these mutations frequently
occur, although another study showed that cats persistently
infected by FECV rarely develop FIP [31].
According to Kipar et al. [32], an increase in viral rep-
lication capacity may be a key feature in the development
of FIP. Failure to control FCoV replication could lead to
an increase in viral load, thus increasing the chances that a
pathogenic mutation will be generated [25]. Furthermore,
immunosuppression caused by infection with feline leu-
kemia virus (FELV) or feline immunodeﬁciency virus (FIV)
can reinforce the creation and selection of mutant FIPVs
by increasing the rate of FECV replication in the gut and
inhibitingtheabilityofthehosttoﬁghtmutatedvirusesonce
they are formed. Thus, both viral and host factors determine
the outcome of FCoV infection [4, 7].
3.Hypotheses Related Viral and Host Factors in
the FCoV Pathogenesis
3.1. Quasispecies Theory. Viruses with RNA genomes have
high mutation rates during development and larger viral
genomes have higher mutation rates compared with smaller
genomes. This fact, coupled with its rapid and continuous
replication, allows for rapid production of viral genetic
diversity,includingmutationsthatfacilitateadaptationtothe
host [33].
The high mutation rates in viruses with RNA genomes,
which use RNA polymerase-dependent RNA, occur because
of the absence of proofreading activity in this enzyme. In
coronavirus, although its RNA polymerase has a domain
with exoribonuclease 3 -5  activity [34], a high number
of errors still can occur in the genome, giving rise to a
population of heterogeneous closely related sequences called
quasispecies [17]. In the coronaviruses, quasispecies forma-
tion has been well documented for murine hepatitis virus
(MHV) [35].
FCoV can also form quasispecies with signiﬁcant genetic
heterogeneity, as a result of accumulation of mutations
during viral replication [17, 27, 36]. These viral subpopu-
lations were analyzed by single-strand conformational pol-
ymorphism (SSCP), for polymerase chain reactions (PCR)
products of genes N and 7b [17, 36] .T h e s es t u d i e sd e m -
onstrate that the composition of FCoV quasispecies in a
single cat can diﬀer in diﬀerent organs [17, 36], and that the
heterogeneity of the FCoV genome is related to the severity
and clinical form of FIP and the lesions observed in the
organs of aﬀected animals [17]. New viral strains present in
thesesubpopulationscanaltercelltropismandpathogenicity
and may have a signiﬁcant impact on generating host disease
[13]. However, it still remains unclear if the association
between genetic diversity and pathogenesis can be attributed
to quasispecies dynamics [33]. Moreover, the mere observa-
tion of high levels of genetic variation in RNA viruses is not
proof of the existence of quasispecies. To demonstrate that
RNA viruses form quasispecies, it is necessary to prove that
natural selection acts on the viral population as a unit [37].
3.2. Immune Response Related to Viral-Host Interaction.
An important feature of FCoV pathogenesis is the intrin-
sic resistance of macrophages to FCoV infection [38]. It
has been postulated that the emergence of highly virulent
FIPV biotypes from FECV is accompanied by a dramatic
change in cell tropism that allows FIPV to infect monocytes
and then be disseminated systemically [8, 10, 39].
Macrophages infected with FIPV play a key role in the
immunopathological damage observed in FIP. These cells are
the most predominant inﬂammatory cells in FIP lesions [40]
and viral antigens can be detected in macrophages isolated
frompyogranulomatouslesions[41]andinmonocytes(pro-
genitors of tissue macrophages) isolated from eﬀusions [42].
Moreover, the decrease of CD4 T cells and, especially, CD8
T cells, as a result of apoptosis is probably related to tumor
necrosis factor alpha (TNF-alpha) released by macrophages
infected with FCoV [11].4 Advances in Virology
Probably ,FIPVreplicatesinmonocytesandmacrophages
because these cells do not express viral antigens on their sur-
face, creating a form of escape through the humoral immune
system [43]. However, FIPV-like cell tropism by macro-
phages is also observed for FECV, because this biotype is also
capable of infecting monocytes and macrophages [14, 44].
Furthermore, cats that do not present with any clinical or
pathological evidence of FIP can maintain viremia in their
monocytes for a period of 3 to 12 months [16, 36, 44],
indicating that the development of FIP is not dependent on
the systemic spread of FCoV [16] and that the susceptibility
of monocytes/macrophages to FCoV infection is only one
of the pathogenic events responsible for FIP. Kipar et al.
[32] showed that, independent of the development of FIP,
infection by FCoV induces proliferation and activation of
monocytes/macrophages.
Host genetic factors are also important for the suscep-
tibility of monocytes to FCoV infection. Studies in vitro
showed that monocytes from diﬀerent cats do not have the
same susceptibility to FCoV infection (by the same strain
of FCoV) suggesting that cellular factors, inﬂuenced by
genetic background and/or diﬀerentiation/activation status,
are very important in determining the occurrence of FIP
[14, 45]. This resistance to FCoV infection seems to occur
also in natural infections. A study in vivo showed that
a small percentage of cats in FCoV endemic households
had no shedding and remained seronegative or had a low
antibody titer over a time period of 5 years [46].
An ineﬀective immune response against FCoV infection
seems to be an important factor in FIP pathogenesis [36].
It has been hypothesized that animals with a weak cell-
mediatedimmunity(CMI)incombinationwithastronghu-
moral immune response are likely to develop FIP and cats
with a strong CMI may not develop the disease [47].
There are indications that a strong humoral immune
system plays an adverse role in the development of FIP [48–
50]. The antibody titer, in FIPV infection, is not eﬀective for
elimination of the virus, and, inversely, they enhance FIP
development in vitro [48] and in vivo, in cats previously
immunized against FCoV [50, 51]. The phenomenon an-
tibody-dependent enhancement (ADE) could explain this
accelerateddevelopmentofFIPinthepresenceofantibodies.
In ADE, antibodies might help the spread of the virus in
an infected cat by facilitating the virus uptake through the
formation of virus-antibody complexes that are taken up by
uninfected monocytes/macrophages via the Fc receptor [49].
A recent study in vitro showed that viral plasma membrane-
bound proteins of FCoV (S and M) were internalized by
monocytes upon antibody addition [52].
Diﬀerently,ithasbeenproposedthatADEdoesnotoccur
in cats with strong CMI, even if they possess anti-FCoV an-
tibodies, escaping from FIP development [50].
Signiﬁcant diﬀerences found in the composition and
functionalstateoflymphatictissuesfromFcoV-infectedcats,
with and without clinical signs of FIP, have been proposed to
play an important role in FIP pathogenesis [32, 45, 53, 54].
CatsinfectedwithFCoV,butwithoutclinicalsignsofFIP,
generally exhibit B and T cells hyperplasia with high lym-
phocyte proliferation [53–55] and exhibit higher expression
levels of feline interleukin- (IL-) 10 in the spleen, as shown
by quantitative real-time PCR (qRT-PCR). In addition, these
cats have decreased IL-6 levels [32]. In contrast, Takano
et al. [56] showed that peripheral blood mononuclear cells
(PBMCs) from FIP cats displayed higher IL-6 expression
compared to the same cells from SPF cats and suggest that
IL-6 is involved in the development of immune-complex-
mediated vasculitis and, therefore, in FIP pathogenesis. This
probably occurs due to the action of IL-6 to recruit and
activate T cells and macrophages, to expand cytotoxic T
lymphocytes, to modulate the diﬀerentiation of plasma cells
and promote increase of vascular permeability [57]. In
the central nervous system IL-6 contributes to immune-
mediated destruction observed in this tissue from cats
with neurological clinical sings of FIP [57].
IL-6 is negatively regulated by IL-10 [58]. IL-10 stimu-
lates Natural killer cells positively regulates the expression of
Fcγ I receptors and antibody-dependent cellular cytotoxicity.
This cytotoxicity probably contributes to viral elimination
[59] and to the low viral loads observed in asymptomatic,
FCoVcarriercats[15].However,anotherstudyreportedthat
high viral load is not related to the development of FIP [16].
Furthermore, IL-10 negatively regulates the expression of
β2-integrins on monocytes, reducing their ability to adhere
to endothelial cells and causing vasculitis [6]. However,
the role of IL-10 in protection against FIP requires further
study, because Dean and coauthors [60]o b s e r v e dh i g hI L -
10 expression levels in tissues of cats infected with a highly
pathogenic FIPV strain (FIPV UCD8).
Lymphoid depletion has been reported in lymphatic
tissues [54, 60] and in blood [55] of FcoV-infected animals,
with clinical signs of FIP. This lymphoid depletion is likely
due to apoptosis, probably mediated by TNF-alpha release,
infected macrophages, and signiﬁcantly decreased IL-12 p40
expression [32, 60]. This decrease in IL-12 p40 coupled with
the presence of large numbers of activated macrophages in
the lymphatic tissue and granulomatous inﬁltrates are signs
ofimmuneresponsefailure[32].IL-12andInterferon-(IFN-
) gamma coordinate the link between pathogen recognition
by innate immune cells and the induction of speciﬁc immu-
nity, by mediating a positive feedback to amplify the Th1
response (cell-mediated). IFN-gamma is an important cy-
tokine for the Th1 immune response by inducing eﬀector
mechanisms such as innate cell-mediated immunity, speciﬁc
cytotoxic immunity, and macrophage activation [61].
Cytokine mRNA measurements from PBMC from cats
previously immunized with an avirulent FIP strain (FIPV-
UCD1) and then challenge-exposed to a highly virulent cat
passaged strain (FIPV-UCD8) with classical eﬀusive FIP and
noneﬀusive FIP showed that disease, regardless of form,
is associated with a strong TNF-alpha mRNA response in
PBMC and a failure to induce IFN-gamma mRNA. In
contrast, asymptomatic cats of the same study failed to
upregulate TNF-alpha mRNA and were observed in one
asymptomatic cat strong IFN-gamma mRNAresponses [62].
TNF-alphamRNAresponsetendstofavorTh2immunity
(humoral), while the IFN-gamma mRNA response favors
Th1 immunity [62]. In FCoV-endemic cattery without a case
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expressing IFN-gamma is signiﬁcantly high, suggesting that
thiscytokine,togetherwithIL-1β,mightprotectinfectedcats
from the disease [63].
Diﬀerently, another study showed high levels of IFN-
gamma mRNA in tissues with inﬂammatory lesions of FIP
indicating that the infection is not controlled only by the
inﬂammatory response [40]. According to these authors,
probably, cytokine proﬁles that run on samples from tissues
with relevant inﬂammatory lesions could reﬂect the local
cytokine response more adequately than in PBMC. A study
with cats naturally infected with FCoV with clinical FIP and
FCoV-infected clinically normal animals showed that cats
with FIP do not have increased serum IFN-gamma con-
centrations [64] suggesting low IFN-gamma expression by
PBMC like that mentioned by Berg et al. [40] or depleted
numbers of lymphocytes in the blood or lymph nodes [54].
Moreover,catsnaturallyinfectedwithFCoV,withclinical
eﬀusive FIP, had IFN-gamma concentrations in the eﬀu-
sions 40-fold higher than the serum concentrations of this
cytokine in the same animals [64]. This suggests that the
IFN-gamma present in the eﬀusions is produced by cells
within FIP lesions, as reported by Berg et al. [40].
A recent study with clinically normal cats naturally in-
fected with FCoV and cats with eﬀusive FIP showed high
serum IFN-gamma concentrations in cats clinically normal
and high IFN-gamma concentration of the FIP eﬀusions.
This suggests that although cats resistant to FCoV infection
have strong CMI as measured by serum IFN gamma produc-
tion, CMI is also likely to be involved in the pathogenesis
of FIP, albeit at a tissue level, as evidenced by the high IFN-
gamma concentration of the FIP eﬀusions [64].
Another important factor involved in the pathogenesis of
FIP is systemic inﬂammatory reaction. Acute phase proteins
(APP) are plasma proteins produced by hepatocytes during
systemic inﬂammation [65]. The major feline APP is α1-acid
glycoprotein (AGP) [66]. In humans AGP is overexpressed
during systemic inﬂammatory responses and its function
appears to be related to an immunomodulatory activity [65].
In cats with FIP there has been observed increase of
AGP concentration [67–69] and this AGP is hyposialylated
(decrease in the degree of sialylation, a posttranslational
modication) [68]. The decrease in the degree of sialylation is
important for development of FIP. In catteries with endemic
FCoVallcatsrespondtoincreasedviralburdenbyincreasing
theproductionofAGPbutonlycatswithhyposialylatedAGP
have persistently increased AGP levels and develop FIP [67].
Paltrinieri et al. [70] investigated the sialylation pattern of
serum AGP in nonsymptomatic cats infected by FCoV and
its relationship with the amount of FCoVs shed in faeces
and observed that hypersialylation of AGP may be one of
the factors that could explain why FCoV-infected cats do not
develop FIP in spite of the presence of large amount of viral
RNA shed in the environment. Possibly, the hypersialylation
provides protection from the development of FIP [70].
3.3. Distinctive Circulating Virulent and Avirulent Strains.
Recently, Brown et al. [18] formulated a new hypothesis
explaining FIP pathogenesis, which suggests the existence
of two diﬀerent strains, virulent and avirulent, circulating
among feline populations. These authors performed phylo-
genetic analysis of partial sequences from ORFs M, S, 3c,
and 7b, isolated from FCoV carrier cats, with and without
clinical signs of FIP. From this analysis, the authors inferred
that FIPV and FECV form monophyletic groups, with high
bootstrap values that clearly diﬀerentiate them genetically,
supporting the presence of two circulating strains. However,
more studies are needed using sequences from diﬀerent geo-
graphic regions. In addition, further investigation is required
into the correlation of these strains with host related factors,
such as immune response, to conﬁrm this hypothesis.
4. Conclusion
Despite numerous eﬀorts by the scientiﬁc community to un-
derstand FIP pathogenesis, this disease still remains an enig-
ma. As demonstrated in this review, the causes underlying
FIP pathogenesis are probably multifactorial, with both viral
and host factors as well as viral genetic determinants playing
important roles in FIP pathogenesis. The studies necessary
to show this interaction will likely be complex. Because
FCoV is an RNA virus, it is able to easily mutate, and thus
there are many FCoV viral subpopulations with variations
in diﬀerent regions of its genome. In addition, individual
cats may respond diﬀerently to FCoV infection, suggesting
that the immune response to FIP is complex. Thus, by
deﬁnition,bothoftheFIPpathogenesistheoriespresentedin
thisreviewaretoosimplistic,andfurtherstudiesareessential
toelucidateFIPpathogenesis,andtoobtaininformationthat
will assist in the development of more accurate diagnostic
methods and eﬀective vaccines.
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